Apart from the prognosis-related ISGs described above, the tumor-infiltrating immune cells-related pathways and tumor progression-related pathways (TCR, BCR, p53, JAK-STAT, MAPK, and Notch) enriched in subtype Sub1 cancer samples were identified to predict worse survival in OSCC. This evidence concerns the gene TP53 and cancer.